Project Number 5P50AG005138-35 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for Project 3: Effects of Type 2 Diabetes (T2D) and Alzheimer disease (AD) on angiogenesis and angiogenic complexes Research Categorization Primary Disease / Condition Alzheimer's Disease Vascular Dementia/Dysfunction CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 10. Metabolism and Bioenergetics b. Insulin Resistance and Type II Diabetes Category F. Research Resources 1. Alzheimer's Disease Centers Researcher and Organization Principal Investigator ROBAKIS, NIKOLAOS K Principal Investigator First Name NIKOLAOS K Principal Investigator Last Name ROBAKIS Awardee Organization ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-15-002: Alzheimer's Disease Research Centers (P50) FY Overall Cost $245,955 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official SILVERBERG, NINA B Related Resources Repository [NIAGADS] Transethnic GWAS Summary Statistics - Jun et al. (2017) [NIAGADS] ADGC African American Summary Statistics- Reitz et al. (2013) [NIAGADS] ADGC Neuropath Summary Stats and Phenotypes- Beecham et al. (2014) [NIAGADS] ADGC Summary Statistics- Naj et al. (2011) [NIAGADS] ADC1- Alzheimer Disease Center Dataset 1 [NIAGADS] ADC2- Alzheimer Disease Center Dataset 2 [NIAGADS] ADC3- Alzheimer Disease Center Dataset 3 Mount Siniai School of Medicine Alzheimer's Disease Research Center National Alzheimer's Coordinating Center (NACC) [AlzPED] Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model
